文献速递生殖医学

评估高光谱子宫内膜分析作为子宫内膜评估微创技术的可行性:一项先导研究

Evaluating the feasibility of hyperspectral endometrial analysis as a less invasive technique for endometrial evaluation: a pilot study.
PubMed 文献 · Fertil Steril · 2025-09-09

一项前瞻性先导研究在西班牙一家私立生殖诊所纳入年龄≤35岁、有生育力的健康排卵规律志愿者,在改良自然周期中用胚胎移植导管内置微纤维镜结合高光谱相机采集子宫内膜光谱。研究识别出26个可区分分泌早、中、晚期的波长特征,预测模型平均准确率87.60%(95%CI:87.08%-88.11%),平均曲线下面积79.41%(95%CI:78.32%-80.50%)。作者认为该技术首次显示高光谱子宫内膜分析评估分泌期分子变化的可行性,但需在不孕患者中进一步前瞻性研究评估临床效用。

要点

  • 高光谱子宫内膜分析可采集分泌期子宫内膜光谱特征。
  • 26个波长特征可区分分泌早、中、晚期。
  • 预测模型平均准确率87.60%,平均曲线下面积79.41%。

核心结论

  • 本研究首次显示高光谱子宫内膜分析用于评估分泌期子宫内膜分子变化的可行性,鉴于该技术微创,或可据此判别种植窗;作者指出需在不孕患者中开展进一步前瞻性研究以评估该技术用于患者分层的临床效用。

研究设计与样本

  • 前瞻性研究,纳入2021年9月至2023年2月在西班牙一家私立生殖诊所自愿参与、年龄≤35岁、有生育力且排卵规律的健康志愿者。

主要发现

  • 分泌早期与中期比较发现290个显著差异波长(占测量总数的97.3%),其中66个强度差异超过50%(强度比>1.5)。
  • 分泌晚期与中期比较发现286个显著差异波长(96%),其中9个强度比>1.5。
  • 分泌早期与晚期比较发现287个显著差异波长(96.3%),其中69个强度比>1.5。
  • 共识别26个波长作为可区分三个分泌期的特征,预测模型区分三个分泌期的平均准确率为87.60%(95%CI:87.08%-88.11%),平均曲线下面积为79.41%(95%CI:78.32%-80.50%)。

关键数值与推荐

  • 高光谱可见光波长特征范围为400-1,000 nm。
  • 26个波长特征用于区分分泌早、中、晚期。
  • 预测模型平均准确率87.60%(95%CI:87.08%-88.11%),平均曲线下面积79.41%(95%CI:78.32%-80.50%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需在不孕患者中开展进一步前瞻性研究以评估该技术用于患者分层的临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the feasibility of using hyperspectral imaging for endometrial evaluation as a potential minimally invasive method to identify the window of implantation within the same embryo transfer cycle. DESIGN: Prospective study. SUBJECTS: Healthy and normo-ovulatory volunteers aged ≤35 years with proven fertility who voluntarily agreed to participate in the study between September 2021 and February 2023 at a private fertility clinic in Spain. INTERVENTIONS: Hyperspectral samples were captured throughout a modified natural menstrual cycle in which ovulation was induced and controlled with human chorionic gonadotropin. A microfiberscope inside an embryo transfer catheter coupled with a hyperspectral camera was introduced into the uterine cavity to capture the endometrial spectra at the fundus level. MAIN OUTCOME MEASURES: The endometrial hyperspectral visible light wavelength signature (in the 400-1,000 nm spectral range) was evaluated as a potential technique to identify the endometrial secretory-phase stages. RESULTS: Comparison of the early and midsecretory stages identified 290 significantly different wavelengths (97.3% of the total number measured), 66 with differences of more than 50% intensity (intensity ratio >1.5); in turn, the late- and mid-secretory comparison resulted in 286 significantly different wavelengths (96%), nine of them with an intensity ratio of >1.5 between them; finally, the comparison of the early- and late-secretory stages found in 287 significantly different wavelengths (96.3%), 69 with and intensity ratio of >1.5 between them. A total of 26 wavelengths were identified as a signature that could distinguish the three different secretory stages. Using this signature, the prediction model performance discriminated the three secretory stages with a mean accuracy of 87.60% (95% confidence interval: [87.08%-88.11%]) and a mean area under the curve of 79.41% (95% confidence interval: [78.32%-80.50%]). CONCLUSION: This present study has shown, for the first time, the feasibility of using hyperspectral endometrial analysis specifically to evaluate the molecular changes that occur in the endometrium during the secretory phase. Thus, given the minimally invasive nature of this technology, the window of implantation could be discriminated in this way. Further prospective studies with infertile patients will be required to evaluate the clinical utility of this technique in patient stratification.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Marti-Garcia D, Sebastian-Leon P, Alamá P, et al. Evaluating the feasibility of hyperspectral endometrial analysis as a less invasive technique for endometrial evaluation: a pilot study. Fertil Steril. 2025. PMID: 40935278. doi:10.1016/j.fertnstert.2025.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。